Abstract
Objectives
To refine the spectrum of SCN1A-epileptic disorders other than Dravet syndrome (DS) and genetic epilepsy with febrile seizures plus (GEFS+) and optimize anti-seizure management by correlating phenotype-genotype relationship and functional consequences of SCN1A variants in a cohort of patients.
Methods
Sixteen probands carrying SCN1A pathogenic variants were ascertained via a national collaborative network. We also performed a literature review including individuals with SCN1A variants causing non-DS and non-GEFS+ phenotypes and compared the features of the two cohorts. Whole-cell patch-clamp experiments were performed ...
Seguir leyendo →ENE